Pulmatrix, Inc.

$1.28+1.59%(+$0.02)
TickerSpark Score
56/100
Mixed
90
Valuation
20
Profitability
55
Growth
84
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PULM research report →

52-Week Range1% of range
Low $1.16
Current $1.28
High $9.37

Companywww.pulmatrix.com

Pulmatrix, Inc. , a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.

CEO
Peter Ludlum
IPO
2014
Employees
2
HQ
Lexington, MA, US

Price Chart

-80.12% · this period
$9.09$5.14$1.19May 20Nov 18May 20

Valuation

Market Cap
$4.67M
P/E
-1.03
P/S
0.00
P/B
1.30
EV/EBITDA
-0.29
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-102.06%
ROIC
-128.49%

Growth & Income

Revenue
$0 · -100.00%
Net Income
$-5,162,000 · 46.00%
EPS
$-1.41 · 46.18%
Op Income
$-5,169,000
FCF YoY
51.12%

Performance & Tape

52W High
$9.37
52W Low
$1.16
50D MA
$1.51
200D MA
$3.33
Beta
1.94
Avg Volume
52.23K

Get TickerSpark's AI analysis on PULM

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Jan 26, 23Siegert Michelleother9,900
Jan 26, 23Wasilewski Margaretother11,400
Jan 26, 23Raad Teofilo Davidother34,900
Jan 26, 23Bazemore Toddother1,700
Jan 26, 23Higgins Michael Jother2,436
Jan 26, 23Cabell Christopherother1,700
Jan 26, 23Varadan Anandother1,700
Jan 26, 23Batycky Richard P.other1,700
Apr 18, 22Ludlum Peterother0
Mar 1, 22Wasilewski Margaretother21,060

Our PULM Coverage

We haven't published any research on PULM yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate PULM Report →

Similar Companies